GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cangene Corporation (FRA:YGE) » Definitions » YoY Rev. per Sh. Growth

Cangene (FRA:YGE) YoY Rev. per Sh. Growth : -35.87% (As of Oct. 2013)


View and export this data going back to . Start your Free Trial

What is Cangene YoY Rev. per Sh. Growth?

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months. Cangene's YoY Rev. per Sh. Growth for the quarter that ended in Oct. 2013 was -35.87%.

Cangene's Revenue per Share for the three months ended in Oct. 2013 was €0.27.


Cangene YoY Rev. per Sh. Growth Historical Data

The historical data trend for Cangene's YoY Rev. per Sh. Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cangene YoY Rev. per Sh. Growth Chart

Cangene Annual Data
Trend Jul04 Jul05 Jul06 Jul07 Jul08 Jul09 Jul10 Jul11 Jul12 Jul13
YoY Rev. per Sh. Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 55.27 -24.22 -8.50 -13.87 6.65

Cangene Quarterly Data
Jan09 Apr09 Jul09 Oct09 Jan10 Apr10 Jul10 Oct10 Jan11 Apr11 Jul11 Oct11 Jan12 Apr12 Jul12 Oct12 Jan13 Apr13 Jul13 Oct13
YoY Rev. per Sh. Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 79.91 -25.13 46.33 -19.60 -35.87

Cangene YoY Rev. per Sh. Growth Calculation

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months.

Cangene's YoY Rev. per Sh. Growth for the fiscal year that ended in Jul. 2013 is calculated as:

YoY Rev. per Sh. Growth (A: Jul. 2013 )
=(Revenue per Share (A: Jul. 2013 )-Revenue per Share (A: Jul. 2012 ))/ | Revenue per Share (A: Jul. 2012 ) |
=(1.444-1.354)/ | 1.354 |
=6.65 %

Cangene's YoY Rev. per Sh. Growth for the quarter that ended in Oct. 2013 is calculated as:

YoY Rev. per Sh. Growth (Q: Oct. 2013 )
=(Revenue per Share (Q: Oct. 2013 )-Revenue per Share (Q: Oct. 2012 )) / | Revenue per Share (Q: Oct. 2012 )) |
=(0.27-0.421)/ | 0.421 |
=-35.87 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cangene YoY Rev. per Sh. Growth Related Terms

Thank you for viewing the detailed overview of Cangene's YoY Rev. per Sh. Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Cangene (FRA:YGE) Business Description

Traded in Other Exchanges
N/A
Address
Cangene Corporation is a fully integrated developer and manufacturer of immune therapeutics, primarily targeting infectious disease, hematology, transplantation and biodefense applications. The company manages its business and evaluate performance based on two operating segments: biopharmaceutical operations and contract services. Revenues are generated from product sales, and contract manufacturing and contract-R&D services.

Cangene (FRA:YGE) Headlines

No Headlines